Pacific Bio (PACB) Tops Q3 EPS by 1c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $23.5 million versus the consensus estimate of $28.55 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results
• Paychex beats fourth quarter EPS estimates, stock slides